Zusammenfassung
Pneumologische Notfälle in der Rheumatologie sind seltene, im Einzelfall lebensbedrohliche Krankheitsbilder, die bei Patienten mit entzündlichen rheumatischen Systemerkrankungen als Komplikation der Grunderkrankung oder der Therapie auftreten können. Vor allem die diffuse alveoläre Hämorrhagie, Trachealstenosen, akute Pneumonitiden und schließlich der medikamenteninduzierte Lungenschaden gehören in diese Kategorie. Das erfolgreiche Management dieser Fälle erfordert aufseiten der Rheumatologie eine intensive Zusammenarbeit mit der Pneumologie. Diese trägt mit ihren Erfahrungen in der Betreuung verwandter Krankheitsbilder, ihren speziellen endoskopischen Techniken sowie den verschiedenen Formen der Beatmung unverzichtbare Verfahren der Diagnostik und supportiven Therapie bei. Ziel der vorliegenden Übersicht ist die Darstellung des aktuellen Standes der Diagnostik und der modernen Behandlungsmöglichkeiten inklusive der B-Zell-gerichteten Therapien.
Abstract
Pulmonary emergencies in rheumatic diseases are rare, potentially life-threatening conditions that occur either as a manifestation of the disease itself or as an adverse event of immunosuppressive treatment. Diffuse alveolar hemorrhage, tracheal stenosis, acute pneumonitis and drug-induced lung injury belong to this category. The management of these emergencies requires intensive cooperation between rheumatology and pulmonology. The latter contributes its experience in the care of related conditions, specific endoscopic techniques and local interventions as well as the indispensable and life-supporting forms of assisted ventilation. The present article summarizes the current knowledge on diagnostic and therapeutic procedures including the newly available B-cell directed treatments.
Literatur
Abramson SB, Dobro J, Eberle MA et al (1991) Acute reversible hypoxemia in systemic lupus erythematosus. Ann Intern Med 114:941–947
Alarcon GS, Kremer JM, Macaluso M et al (1997) Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. Ann Intern Med 127:356–364
Buttgereit F, Kaschke O, Krause A et al (1997) Protracted course of polychondritis as the etiology of progressive nose deformity, subglottic tracheal stenosis and inner ear hearing loss. Laryngorhinootologie 76:46–49
Buttgereit F, Wehling M, Burmester GR (1998) A new hypothesis of modular glucocorticoid actions. Arthritis Rheum 41:761–767
Casian A, Jayne D (2011) Management of alveolar hemorrhage in lung vasculitides. Semin Respir Crit Care Med 32:335–345
Casian A, Jayne D (2011) Plasma exchange in the treatment of Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis. Curr Opin Rheumatol 23:12–17
Cordier JF, Cottin V (2011) Alveolar hemorrhage in vasculitis: primary and secondary. Semin Respir Crit Care Med 32:310–321
Chikura B, Lane S, Dawson JK (2009) Clinical expression of leflunomide-induced pneumonitis. Rheumatology 48:1065–1068
Erickson VR, Hwang PH (2007) Wegener’s granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg 15:170–176
Ernst A, Rafeq S, Boiselle P et al (2009) Relapsing polychondritis and airway involvement. Chest 135:1024–1030
Espinosa G, Cervera R (2010) Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol 6:296–300
Hoffman GS, Thomas-Golbanov CK, Chan J et al (2003) Treatment of subglottic stenosis, due to Wegener’s granulomatosis, with intralesional corticosteroids and dilation. J Rheumatol 30:1017–1021
Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: Does it occur as persistent disease stage? Ann Rheum Dis 69:1934–1939
Jayne DRW, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180–2188
Jones RB, Tervaert JWC, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211–220
Kremer JM, Alarcón GS, Weinblatt ME et al (1997) Clinical, laboratory, radiographic and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. Arthritis Rheum 40:1829–1837
Langford CA, Sneller MC, Hallahan CW et al (1996) Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Arthritis Rheum 39:1754–1760
Malik SW, Myers JL, DeRemee RA, Specks U (1996) Lung toxicity with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 154:1851–1856
Matthay RA, Schwarz MI, Petty TL et al (1975) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine(Baltimore) 54(5):397–409
Navarra SV, Guzman RM, Gallacher AE et al (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377(9767):721–731
Niles JL, Böttinger EP, Saurina GR et al (1996) The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 156:440–445
Orabi AA, Negam A, Bulman C (2007) Subglottic and tracheal stenosis associated with multifocal fibrosclerosis. Acta Otolaryngol 127:662–666
Pego-Reigosa JM, Medeiros DA, Isenberg DA (2009) Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin Rheumatol 23:469–480
Salliot C, Heijde D van der (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68:1100–1104
Schokkenbroek AA, Franssen CFM, Dikkers FG (2008) Dilatation tracheoscopy for laryngeal and tracheal stenosis in patients with Wegener’s granulomatosis. Eur Arch Otorhinolaryngol 265:549–555
Schwarz MI, Zamora MR, Hodges TN et al (1998) Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 113:1609–1615
Sinico RA, Di Toma L, Maggiore U et al (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52:2926–2935
Spector JI, Zimbler H, Ross JS (1979) Early-onset cyclophosphamide- induced interstitial pneumonitis. JAMA 242:2852–2854
Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232
Danksagung
Frau Meike Zahnen danken wir für die sorgfältige Präparation des Manuskriptes. Frau Professor Dr. Beate Stöcklhuber (Radiologische Abteilung des Städtischen Krankenhauses Kiel) sei herzlich gedankt für die Überlassung der CT-Aufnahmen für Abb. 2.
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schröder, J., Zeuner, R., Bewig, B. et al. Pneumologische Notfälle bei Kollagenosen und Vaskulitiden. Z. Rheumatol. 71, 278–287 (2012). https://doi.org/10.1007/s00393-011-0916-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-011-0916-1